Heart, Lung and Circulation
Volume 19, Issue 2 , Pages 81-89 , February 2010

The Combined Pharmacological Stress Echocardiography Protocol for Predicting Improvement of Global Left Ventricular Systolic Function After Revascularisation

  • Zainab Abdel-Salam, MD
    • ,
  • Wail Nammas, MD

      Affiliations

    • Corresponding Author InformationCorresponding author at: Cardiology Department, Ain Shams University Hospitals, Faculty of Medicine, Ain Shams University, Abbassia, P.O. 11381, Cairo, Egypt. Tel.: +20 2 248 20 415; fax: +20 2 248 20 416.

Received 7 February 2009 ,Revised 20 June 2009 ,Accepted 17 August 2009.

References 

  1. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993;87(1):1–20
  2. Hoffmann R. Stress echocardiography before and after interventional therapy. In:  Marwick TH editors. Cardiac stress testing and imaging. A clinician's guide. New York: Churchill Livingston; 1996;p. 355–367
  3. Beller GA. Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation. 1996;94(11):2712–2719
  4. Jiménez Borreguero LJ, Ruiz-Salmerón R. Assessment of myocardial viability in patients before revascularization. Rev Esp Cardiol. 2003;56(7):721–733
  5. Marwick TH. Stress echocardiography. Heart. 2003;89(1):113–118
  6. Grayburn PA. Defining the threshold of myocardial viability by dobutamine echocardiography. Int J Cardiol. 2003;90(1):31–32
  7. Varga A, Ostojic M, Djordjevic-Dikic A, Sicari R, Pingitore A, Nedeljkovic I, et al. Infra-low dose dipyridamole test. A novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J. 1996;17(4):629–634
  8. Picano E, Ostojic M, Varga A, Sicari R, Djordjevic-Dikic A, Nedeljkovic I, et al. Combined low dose dipyridamole–dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol. 1996;27(6):1422–1428
  9. Abdel-Salam Z, Nammas W. Which protocol for which segment: a comparative study of different pharmacological stress echocardiography protocols for predicting viability in segments with varying degrees of dyssynergy. Echocardiography. 2009;26(5):541–548
  10. Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation. 1997;95(6):1402–1410
  11. Knudsen AS, Darwish AZ, Nørgaard A, Gøtzsche O, Thygesen K. Time course of myocardial viability after acute myocardial infarction: an echocardiographic study. Am Heart J. 1998;135(1):51–57
  12. Chaudhry FA, Singh B, Galatro K. Reversible left ventricular dysfunction. Echocardiography. 2000;17(5):495–506
  13. Meluzín J, Cerný J, Frélich M, Stetka F, Spinarová L, Popelová J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol. 1998;32(4):912–920
  14. Sanchis J, Bodí V, Insa L, Gómez-Aldaraví R, Berenguer A, López-Lereu MP, et al. Low-dose dobutamine testing using contrast left ventriculography in the same session as coronary angiography predicts the improvement of left ventricular function after coronary angioplasty in postinfarction patients. Am J Cardiol. 1999;83(1):15–20
  15. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation. 1997;95(7):1961–1971
  16. Ausma J, Cleutjens J, Thoné F, Flameng W, Ramaekers F, Borgers M. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem. 1995;147(1–2):35–42
  17. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 2003;75(2):S656–S660
  18. Saffitz JE, Yamada KA. Do alterations in intercellular coupling play a role in cardiac contractile dysfunction?. Circulation. 1998;97(7):630–632
  19. Elsässer A, Müller KD, Skwara W, Bode C, Kübler W, Vogt AM. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J Am Coll Cardiol. 2002;39(7):1189–1198
  20. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation. 1996;93(8):1556–1566
  21. Hendel RC, Chaudhry FA, Bonow RO. Myocardial viability. Curr Probl Cardiol. 1996;21(3):145–221
  22. Lu M, Zhao S, Wei Y, Wang C, Jiang S, Huang L, et al. Detection of viable myocardium by low dose of dobutamine cine MR imaging in miniswine. Chin Med J. 2003;116(6):893–896
  23. Zeng X, Shu XH, Pan CZ, Li Q, Guo SZ, Liu SZ, et al. Real-time myocardial contrast echocardiography can predict functional recovery and left ventricular remodeling after revascularization in patients with ischemic heart disease. Chin Med J. 2007;120(21):1890–1893
  24. Meluzín J, Cerný J, Spinarová L, Toman J, Groch L, Stetka F, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability. Eur J Heart Fail. 2003;5(1):85–93
  25. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32(7):375–410
  26. Trent RJ, Waiter GD, Hillis GS, McKiddie FI, Redpath TW, Walton S. Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisation. Heart. 2000;83(1):40–46
  27. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation. 1995;91(10):2556–2565
  28. Meluzin J, Cigarroa CG, Brickner ME, Cerny J, Spinarova L, Frelich M, et al. Dobutamine echocardiography in predicting improvement in global left ventricular systolic function after coronary bypass or angioplasty in patients with healed myocardial infarcts. Am J Cardiol. 1995;76:877–880
  29. Senior R, Lahiri A. Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging. Heart. 1999;82(6):668–673
  30. Piscione F, De Luca G, Perrone-Filardi P, Prastaro M, Pace L, Galasso G, et al. Relationship between contractile reserve, Tl-201 uptake, and collateral angiographic circulation in collateral-dependent myocardium: implications regarding the evaluation of myocardial viability. J Nucl Cardiol. 2003;10(1):92–94
  31. Auerbach MA, Schoder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 1999;99:2921–2926
  32. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol. 1999;33(7):1848–1854
  33. Meluzín J, Cerný J, Groch L, Frélich M, Stetka F, Spinarová L, et al. Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction. Int J Cardiol. 2003;90(1):23–31

PII: S1443-9506(09)01055-5

doi: 10.1016/j.hlc.2009.08.008

Heart, Lung and Circulation
Volume 19, Issue 2 , Pages 81-89 , February 2010

Article Tools

* Image Usage & Resolution